AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their […]
Read More
In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B […]
Read More
The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 17, 2020 and end September 14, 2020. Mandatory […]
Read More
Merck & Co. is communicating directly with covered entities asking for contract pharmacy claim data to be submitted to Merck via a secure web portal. Merck states the data will […]
Read More
HRSA has indicated it will allow a hospital to accelerate timelines for its offsite locations to begin participating in the 340B Drug Discount Program. Previously, offsite locations were required to […]
Read More
The White House Office of Management and Budget (OMB) approved the Centers for Medicare & Medicaid Services’ (CMS) plan, proposed September 30, 2019, to survey 340B hospitals for their net […]
Read More
This article was originally published on March 25th and was updated on April 23rd. It is being updated as new information becomes available. We wanted to provide updates on the […]
Read More
We wanted to share an urgent update on the impending billing changes that were scheduled to take effect on 4/1/2020. In a communication we acquired today from Jessin Joseph, Pharmacy […]
Read More
Consolidated Health Center & FQHC Look-a-Likes The 2020 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung […]
Read More
The Health Resources and Services Administration (HRSA) has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 19, 2019, and end September 16, 2019. […]
Read More
Beginning with cost reporting periods ending on or after January 1, 2026, many acute care hospitals will face a new Medicare cost reporting requirement: Worksheet S-12. For the first time, […]
By Jonah Gjertson, Senior Consultant at Blue & Co. As of June 29, 2026, 168 buy-sell transactions occurred across the United States, with California, Ohio, Texas, New York, and Illinois […]
By Jonah Gjertson, Senior Consultant at Blue & Co. North American automotive manufacturing held steady through May 2026 compared to the same period in 2025. Looking at the numbers, Volkswagen, […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
